Bayer HealthCare

News Bayer HealthCare

• After a good third quarter: Bayer confirms Group outlook

  The Bayer Group achieved further sales growth and significantly increased earnings in the third quarter of 2011. “It was a good quarter for Bayer,” Management Board Chairman Dr. Marijn Dekkers said Thursday at the presentation of the interim report. He described the continuing growth momentum in the more

• Bayer off to a successful start to 2011

  The Bayer Group got off to a successful start to 2011. “All three subgroups contributed to the strong start to the year with sales and earnings increases,” Bayer CEO Dr. Marijn Dekkers explained on Thursday when the company’s first-quarter results were released. He was especially pleased at how well more

• Bayer Passes First REACH Milestone

  Bayer has successfully completed the registration of 125 large-volume chemicals under the European Union’s REACH Regulation by the specified deadline of December 1, 2010. According to European law, this is an essential requirement for the continued production and marketing of these products. More th more

Publications Bayer HealthCare

• Synthesis and Physicochemical Characterisation of Gd‐DTPA Derivatives as Contrast Agents for MRI

  Abstract Paramagnetic magnetic resonance imaging (MRI) contrast agents are the compounds most used in clinical studies. Among these, the derivatives of Gd‐DTPA (gadoliniumdiethylenetriaminepentaacetic acid, Magnevist®, Bayer HealthCare) have been extensively studied. The first part of this work c more

• Synthesis and Physicochemical Characterisation of Gd‐DTPA Derivatives as Contrast Agents for MRI

  Abstract Paramagnetic magnetic resonance imaging (MRI) contrast agents are the compounds most used in clinical studies. Among these, the derivatives of Gd‐DTPA (gadoliniumdiethylenetriaminepentaacetic acid, Magnevist®, Bayer HealthCare) have been extensively studied. The first part of this work c more

Websites Bayer HealthCare